140 related articles for article (PubMed ID: 29682583)
1. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in
Fan XM; Huang CL; Wang YM; Li N; Liang QL; Luo GA
J Diabetes Res; 2018; 2018():8237590. PubMed ID: 29682583
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy.
Hu J; Fan X; Meng X; Wang Y; Liang Q; Luo G
Planta Med; 2014 Jun; 80(8-9):614-21. PubMed ID: 24853762
[TBL] [Abstract][Full Text] [Related]
4. Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression.
Zhao H; Li X; Zhao T; Zhang H; Yan M; Dong X; Chen P; Ma L; Li P
PLoS One; 2017; 12(2):e0171475. PubMed ID: 28182710
[TBL] [Abstract][Full Text] [Related]
5. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
[TBL] [Abstract][Full Text] [Related]
6. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
[TBL] [Abstract][Full Text] [Related]
7. Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice.
Liu P; Peng L; Zhang H; Tang PM; Zhao T; Yan M; Zhao H; Huang X; Lan H; Li P
Front Physiol; 2018; 9():343. PubMed ID: 29681863
[TBL] [Abstract][Full Text] [Related]
8. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
9. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
10. Calycosin Ameliorates Diabetes-Induced Renal Inflammation via the NF-κB Pathway In Vitro and In Vivo.
Zhang YY; Tan RZ; Zhang XQ; Yu Y; Yu C
Med Sci Monit; 2019 Mar; 25():1671-1678. PubMed ID: 30830898
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of NaoXinTong Capsule on the developed diabetic nephropathy in db/db mice.
Yang S; Chen Y; Duan Y; Ma C; Liu L; Li Q; Yang J; Li X; Zhao B; Wang Y; Qian K; Liu M; Zhu Y; Yang X; Han J
Biomed Pharmacother; 2019 Oct; 118():109389. PubMed ID: 31545275
[TBL] [Abstract][Full Text] [Related]
12. Tangshen formula improves diabetic nephropathy in STZ-induced diabetes rats fed with hyper-methionine by regulating the methylation status of kidney.
Jiang Y; Deng G; Liu C; Tang H; Zheng J; Kong X; Zhao M; Liu Y; Gao P; Li T; Zhao H; Cao Y; Li P; Ma L
Clin Epigenetics; 2024 Jan; 16(1):1. PubMed ID: 38167534
[TBL] [Abstract][Full Text] [Related]
13. Danzhi Jiangtang Capsule ameliorates kidney injury via inhibition of the JAK-STAT signaling pathway and increased antioxidant capacity in STZ-induced diabetic nephropathy rats.
Sun M; Bu W; Li Y; Zhu J; Zhao J; Zhang P; Gu L; Zhang W; Fang Z
Biosci Trends; 2019 Jan; 12(6):595-604. PubMed ID: 30606979
[TBL] [Abstract][Full Text] [Related]
14. Protective Role of Tangshen Formula on the Progression of Renal Damage in
Wang Q; Tian X; Zhou W; Wang Y; Zhao H; Li J; Zhou X; Zhang H; Zhao T; Li P
J Diabetes Res; 2020; 2020():3634974. PubMed ID: 33015191
[TBL] [Abstract][Full Text] [Related]
15. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
16. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
Yan M; Wen Y; Yang L; Wu X; Lu X; Zhang B; Huang W; Li P
Trials; 2016 May; 17(1):259. PubMed ID: 27216240
[TBL] [Abstract][Full Text] [Related]
17. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
18. Fuxin Granules ameliorate diabetic nephropathy in db/db mice through TGF-β1/Smad and VEGF/VEGFR2 signaling pathways.
Zheng W; Qian C; Xu F; Cheng P; Yang C; Li X; Lu Y; Wang A
Biomed Pharmacother; 2021 Sep; 141():111806. PubMed ID: 34246190
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway.
Lei D; Chengcheng L; Xuan Q; Yibing C; Lei W; Hao Y; Xizhi L; Yuan L; Xiaoxing Y; Qian L
Pharmacol Res; 2019 Aug; 146():104320. PubMed ID: 31220559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
